Skip to main content
Clinical Trials/CTRI/2023/06/054377
CTRI/2023/06/054377
Not yet recruiting
Phase 3

Comparative Clinical Study To Evaluate The Efficacy Of Dadru Gajendra Sinh Lepa And Terbinafine Ointment In Management Of Dadru Kushtha W.R.T Tinea Cruris . - NI

Dr Priyanka Pandurang Panchal0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Sponsor
Dr Priyanka Pandurang Panchal
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Priyanka Pandurang Panchal

Eligibility Criteria

Inclusion Criteria

  • i)Patients willing to participate in this trial through written informed consent
  • ii)Patients who are 18 years to 70 years of any sed
  • iii)Patients having specific symptoms of dadru kushtha
  • iv)Patients who have controlled DM

Exclusion Criteria

  • i)Person with age below 18 years and with age above 70 years
  • ii)Person having severe/chronic hepatic/renal diseases
  • iii)Person with chronic infectious disease such as active Tuberculosis,Hepatitis B or C,or HIV
  • iv)Chronicity more than 2 years
  • v)Pregnant women and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials